An update on drug-drug interactions for care of the acutely ill in the era of COVID-19.

Asad E PatanwalaNynke G L JagerJohn J RadosevichRoger Brüggemann

Published in: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (2023)

Interpreting and managing DDIs should follow a pharmacologically based approach and a systematic decision-making process to optimize patient outcomes.

Keyphrases

decision making
coronavirus disease
sars cov
healthcare
palliative care
quality improvement
pain management
affordable care act
adverse drug
respiratory syndrome coronavirus
drug induced
chronic pain
health insurance